Literature DB >> 7515954

Willardiines differentiate agonist binding sites for kainate- versus AMPA-preferring glutamate receptors in DRG and hippocampal neurons.

L A Wong1, M L Mayer, D E Jane, J C Watkins.   

Abstract

Concentration jump responses to 5-substituted (S)-willardiines were recorded from dorsal root ganglion (DRG) and hippocampal neurons under voltage clamp. After block of desensitization by concanavalin-A, dose-response analysis for activation of kainate-preferring receptors in DRG neurons gave the potency sequence trifluoromethyl > iodo > bromo approximately chloro > nitro approximately cyano > kainate > methyl > fluoro > (R,S)-AMPA >> willardiine; EC50 values for the most and least potent willardiine derivatives, 5-trifluoromethyl (70 nM) and 5-fluoro (69 microM), differed 1000-fold. The potency sequence for equilibrium responses at AMPA-preferring receptors in hippocampal neurons was strikingly different from that obtained in DRG neurons: fluoro > cyano approximately trifluoromethyl approximately nitro > chloro approximately bromo > (R,S)-AMPA > iodo > willardiine > kainate > methyl. In hippocampal neurons EC50 values for the most and least potent willardiine derivatives, 5-fluoro (1.5 microM) and 5-methyl (251 microM), differed only 170-fold. Consistent with equilibrium potency measurements, in DRG neurons the kinetics of deactivation for willardiines, recorded following a return to agonist-free solution, were rapid for 5-fluoro (tau off = 43 msec) but slow for 5-iodo (tau off = 4.2 sec), while the opposite sequence was observed for hippocampal neurons, slow for 5-fluoro (tau off = 2.1 sec) and rapid for 5-iodo (tau off = 188 msec). The kinetics of recovery from desensitization showed comparable agonist- and cell-dependent differences. Structure-activity analysis for agonist responses recorded from DRG and hippocampal neurons suggests that for both kainate-preferring and AMPA-preferring receptors the binding of willardiines involves interactions with polar groups such that potency is related to ionization of the uracil ring, and hence the electron-withdrawing ability of the 5-position substituent. However, kainate-preferring receptors differ from AMPA-preferring receptors in possessing a lipophilic pocket that further enhances agonist potency by hydrophobic bonding of the 5-substituent. In contrast, AMPA-preferring receptors lack such a lipophilic site, and for 5-position substituents of the same electron-withdrawing ability, potency decreases with increase in size.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7515954      PMCID: PMC6576952     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  16 in total

Review 1.  Glutamate receptor ion channels: structure, regulation, and function.

Authors:  Stephen F Traynelis; Lonnie P Wollmuth; Chris J McBain; Frank S Menniti; Katie M Vance; Kevin K Ogden; Kasper B Hansen; Hongjie Yuan; Scott J Myers; Ray Dingledine
Journal:  Pharmacol Rev       Date:  2010-09       Impact factor: 25.468

2.  Chemical interplay in the mechanism of partial agonist activation in alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors.

Authors:  Kimberly A Mankiewicz; Anu Rambhadran; Lisa Wathen; Vasanthi Jayaraman
Journal:  Biochemistry       Date:  2007-12-15       Impact factor: 3.162

3.  Distinct receptors underlie glutamatergic signalling in inspiratory rhythm-generating networks and motor output pathways in neonatal rat.

Authors:  M F Ireland; F C Lenal; A R Lorier; D E Loomes; T Adachi; T S Alvares; J J Greer; G D Funk
Journal:  J Physiol       Date:  2008-03-13       Impact factor: 5.182

4.  NMR spectroscopy of the ligand-binding core of ionotropic glutamate receptor 2 bound to 5-substituted willardiine partial agonists.

Authors:  Michael K Fenwick; Robert E Oswald
Journal:  J Mol Biol       Date:  2008-03-14       Impact factor: 5.469

Review 5.  The regulation of AMPA receptor-binding sites.

Authors:  K K Dev; J M Henley
Journal:  Mol Neurobiol       Date:  1998       Impact factor: 5.590

6.  High-affinity kainate-type ion channels in rat cerebellar granule cells.

Authors:  K E Pemberton; S M Belcher; J A Ripellino; J R Howe
Journal:  J Physiol       Date:  1998-07-15       Impact factor: 5.182

7.  Activation and desensitization of hippocampal kainate receptors.

Authors:  T J Wilding; J E Huettner
Journal:  J Neurosci       Date:  1997-04-15       Impact factor: 6.167

8.  Structural requirements for novel willardiine derivatives acting as AMPA and kainate receptor antagonists.

Authors:  Julia C A More; Helen M Troop; Nigel P Dolman; David E Jane
Journal:  Br J Pharmacol       Date:  2003-03       Impact factor: 8.739

Review 9.  Kainate receptor signaling in pain pathways.

Authors:  Sonia K Bhangoo; Geoffrey T Swanson
Journal:  Mol Pharmacol       Date:  2012-10-24       Impact factor: 4.436

10.  Characterization of the pharmacology and regional distribution of (S)-[3H]-5-fluorowillardiine binding in rat brain.

Authors:  L M Hawkins; K M Beaver; D E Jane; P M Taylor; D C Sunter; P J Roberts
Journal:  Br J Pharmacol       Date:  1995-10       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.